Publikationen (20) Publikationen von Marina Navarro Peñalver

2024

  1. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

2023

  1. Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation

    European heart journal. Cardiovascular Imaging, Vol. 25, Núm. 1, pp. 75-85

  2. Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants

    Circulation: Genomic and Precision Medicine, Vol. 16, Núm. 5, pp. 434-441

2022

  1. Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1183-1196

  2. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

2021

  1. Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 78, Núm. 17, pp. 1682-1699

  2. Elevated baseline renin levels as a possible cause of worse prognosis of COVID-19 in patients with heart disease

    Revista Espanola de Cardiologia

  3. Prevented Sudden Cardiac Death and Neurologic Recovery in Inherited Heart Diseases

    Frontiers in Cardiovascular Medicine, Vol. 8

  4. Reasons for refusing diagnostic tests and therapeutic recommendations and associated complications in inherited heart diseases. The RELUCTANT study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 526-532

2020

  1. Genetic factors involved in cardiomyopathies and in cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 6

2019

  1. Cardiac Sympathetic Innervation and Appropriate Therapies in Patients With an Implantable Cardioverter-defibrillator in Primary Prevention

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 180-182

  2. Lack of improvement in autonomic cardiac tone after sacubitril/valsartan at lower than target doses

    Journal of Electrocardiology, Vol. 52, pp. 99-100

2018

  1. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 23, Núm. 6, pp. 543-550

2017

  1. Valor del «test de bipedestación» en el diagnóstico y la evaluación de la respuesta al tratamiento con bloqueadores beta en el síndrome de QT largo

    Revista Espanola de Cardiologia, Vol. 70, Núm. 11, pp. 907-914

2016

  1. Factor de transcripción TBX1 en el remodelado cardiaco asociado al infarto de miocardio

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1042-1050

  2. Hypertrophic or hypertensive cardiomyopathy?

    International Journal of Cardiology, Vol. 203, pp. 891-892

  3. Mutation in JPH2 cause dilated cardiomyopathy

    Clinical Genetics

  4. Unclassifiable arrhythmic cardiomyopathy associated with Emery–Dreifuss caused by a mutation in FHL1

    Clinical Genetics, Vol. 90, Núm. 2, pp. 171-176

2013

  1. Beta-trace protein and cystatin C as predictors of major bleeding in non-ST-segment elevation acute coronary syndrome

    Circulation Journal, Vol. 77, Núm. 8, pp. 2088-2096

2012

  1. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure

    Cardiology (Switzerland), Vol. 122, Núm. 3, pp. 158-166